Sensitivity and specificity
This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (July 2020) (Learn how and when to remove this template message)
- Sensitivity measures the proportion of true positives that are correctly identified (e.g., the proportion of those who truly have a condition (affected) who are correctly identified as having some condition).
- Specificity measures the proportion of true negatives (e.g. the proportion of those who truly do not have the condition (unaffected) who are correctly identified as not having the condition).
The terms "true positive" and "true negative" do not refer to benefit. They refer to the presence or absence of a condition. If the condition is a disease, "true positive" means "diseased" and "true negative" means "not diseased".
In medical testing medical tests, sensitivity is a measure of the extent to which true positives (people who truly have a condition) are identified by the test. Sensitivity is defined as the true positive "rate" (TP). This is the percentage (or proportion) of people who truly have the condition that are identified by the test as having the condition. People who truly have the condition but have a negative test for the condition are falsely negative. This is called the false negative "rate" (FN). This is the percentage (or proportion) of people who truly have the condition that are identified (falsely) as not having the condition. The true positive "rate" (TP) and the false negative "rate" (FN) equal 1.0. That is, everyone with a positive test is either a true positive (they tested positive and they truly have the condition) or a false negative (they truly have the disease but they tested negative).
In a diagnostic test, specificity is the extent to which true negatives (people who truly DO NOT have a condition) are correctly identified as not having the condition. Specificity is defined as the true negative "rate" (TN). This is the percentage (or proportion) of people who truly DO NOT have the condition that are identified by the test as NOT having the condition. People who have truly DO NOT have the condition but have a positive test for the condition are falsely positive on the test. This is called the false positive rate" (FP). This is the percentage (or proportion) of people who truly DO NOT have the condition who are identified (falsely) as not having the condition. The true negative "rate" (TN) and the false positive "rate" (FP) equal 1.0.
In a "good" diagnostic test (one that attempts to identify with precision people who have the condition), the false positives (FP) should be very low. That is, people who are identified a having a condition should be highly likely to truly have the condition. This is because people who are identified as having a condition (but do not have it, in truth) may be subjected to: more testing (which could be expensive); stigma (e.g. HIV positive test); anxiety (e.g., I'm sick...I might die).
In testing with one test, everyone with a positive test is either a true positive (they tested positive and they truly have the condition) or a false positive (they tested positive but they truly do not have the condition). Everyone with a negative test is either a false negative (they tested negative but they truly have the condition) or a true negative (they tested negative and they truly do not have the condition).
A test done in a person who has symptoms of a condition (the prior probability of disease is high) and has high sensitivity--0.98 or more--is highly likely to identify a true positive--a person who truly has the condition.
A test done in a person who does not have symptoms of a condition (the prior probability of disease is low) will have a high rate of false positives (FP).
For all testing, both diagnostic and screening, there is a trade-off between sensitivity and specificity.
The terms "sensitivity" and "specificity" were introduced by American biostatistician Jacob Yerushalmy in 1947.
In the terminology true/false positive/negative, true or false refers to the assigned classification being correct or incorrect, while positive or negative refers to assignment to the positive or the negative category.
Application to screening study
Imagine a study evaluating a test that screens people for a disease. Each person taking the test either has or does not have the disease. The test outcome can be positive (classifying the person as having the disease) or negative (classifying the person as not having the disease). The test results for each subject may or may not match the subject's actual status. In that setting:
- True positive: Sick people correctly identified as sick
- False positive: Healthy people incorrectly identified as sick
- True negative: Healthy people correctly identified as healthy
- False negative: Sick people incorrectly identified as healthy
|Total population||Condition positive||Condition negative||Prevalence = Σ Condition positive/||Accuracy (ACC) = Σ True positive + Σ True negative/|
|True positive||False positive,
Type I error
|Positive predictive value (PPV), Precision = Σ True positive/||False discovery rate (FDR) = Σ False positive/|
Type II error
|True negative||False omission rate (FOR) = Σ False negative/||Negative predictive value (NPV) = Σ True negative/|
|True positive rate (TPR), Recall, Sensitivity, probability of detection, Power = Σ True positive/||False positive rate (FPR), Fall-out, probability of false alarm = Σ False positive/||Positive likelihood ratio (LR+) = TPR/||Diagnostic odds ratio (DOR) = LR+/||F1 score = 2 · Precision · Recall/|
|False negative rate (FNR), Miss rate = Σ False negative/||Specificity (SPC), Selectivity, True negative rate (TNR) = Σ True negative/||Negative likelihood ratio (LR−) = FNR/|
Consider the example of a medical test for diagnosing a condition. Sensitivity refers to the test's ability to correctly detect ill patients who do have the condition. In the example of a medical test used to identify a condition, the sensitivity (sometimes also named the detection rate in a clinical setting) of the test is the proportion of people who test positive for the disease among those who have the disease. Mathematically, this can be expressed as:
A negative result in a test with high sensitivity is useful for ruling out disease. A high sensitivity test is reliable when its result is negative, since it rarely misdiagnoses those who have the disease. A test with 100% sensitivity will recognize all patients with the disease by testing positive. A negative test result would definitively rule out presence of the disease in a patient. However, a positive result in a test with high sensitivity is not necessarily useful for ruling in disease. Suppose a 'bogus' test kit is designed to always give a positive reading. When used on diseased patients, all patients test positive, giving the test 100% sensitivity. However, sensitivity does not take into account false positives. The bogus test also returns positive on all healthy patients, giving it a false positive rate of 100%, rendering it useless for detecting or "ruling in" the disease.
Sensitivity is not the same as the precision or positive predictive value (ratio of true positives to combined true and false positives), which is as much a statement about the proportion of actual positives in the population being tested as it is about the test.
The calculation of sensitivity does not take into account indeterminate test results. If a test cannot be repeated, indeterminate samples either should be excluded from the analysis (the number of exclusions should be stated when quoting sensitivity) or can be treated as false negatives (which gives the worst-case value for sensitivity and may therefore underestimate it).
Consider the example of a medical test for diagnosing a disease. Specificity relates to the test's ability to correctly reject healthy patients without a condition. Specificity of a test is the proportion of who truly do not have the condition who test negative for the condition. Mathematically, this can also be written as:
A positive result in a test with high specificity is useful for ruling in disease. The test rarely gives positive results in healthy patients. A positive result signifies a high probability of the presence of disease.
A test with a higher specificity has a lower type I error rate.
In medical diagnosis, test sensitivity is the ability of a test to correctly identify those with the disease (true positive rate), whereas test specificity is the ability of the test to correctly identify those without the disease (true negative rate). If 100 patients known to have a disease were tested, and 43 test positive, then the test has 43% sensitivity. If 100 with no disease are tested and 96 return a completely negative result, then the test has 96% specificity. Sensitivity and specificity are prevalence-independent test characteristics, as their values are intrinsic to the test and do not depend on the disease prevalence in the population of interest. Positive and negative predictive values, but not sensitivity or specificity, are values influenced by the prevalence of disease in the population that is being tested. These concepts are illustrated graphically in this applet Bayesian clinical diagnostic model which show the positive and negative predictive values as a function of the prevalence, the sensitivity and specificity.
The relationship between a screening tests' positive predictive value, and its target prevalence, is proportional - though not linear in all but a special case. In consequence, there is a point of local extrema and maximum curvature defined only as a function of the sensitivity and specificity beyond which the rate of change of a test's positive predictive value drops at a differential pace relative to the disease prevalence. Using differential equations, this point was first defined by Balayla et al.  and is termed the prevalence threshold (). The equation for the prevalence threshold is given by the following formula, where a = sensitivity and b = specificity:
Where this point lies in the screening curve has critical implications for clinicians and the interpretation of positive screening tests in real time.
It is often claimed that a highly specific test is effective at ruling in a disease when positive, while a highly sensitive test is deemed effective at ruling out a disease when negative. This has led to the widely used mnemonics SPPIN and SNNOUT, according to which a highly specific test, when positive, rules in disease (SP-P-IN), and a highly 'sensitive' test, when negative rules out disease (SN-N-OUT). Both rules of thumb are, however, inferentially misleading, as the diagnostic power of any test is determined by both its sensitivity and its specificity.
The tradeoff between specificity and sensitivity is explored in ROC analysis as a trade off between TPR and FPR (that is, recall and fallout). Giving them equal weight optimizes informedness = specificity+sensitivity-1 = TPR-FPR, the magnitude of which gives the probability of an informed decision between the two classes (>0 represents appropriate use of information, 0 represents chance-level performance, <0 represents perverse use of information).
The sensitivity index or d' (pronounced 'dee-prime') is a statistic used in signal detection theory. It provides the separation between the means of the signal and the noise distributions, compared against the standard deviation of the noise distribution. For normally distributed signal and noise with mean and standard deviations and , and and , respectively, d' is defined as:
An estimate of d' can be also found from measurements of the hit rate and false-alarm rate. It is calculated as:
- d' = Z(hit rate) – Z(false alarm rate),
where function Z(p), p ∈ [0,1], is the inverse of the cumulative Gaussian distribution.
d' is a dimensionless statistic. A higher d' indicates that the signal can be more readily detected.
- A worked example
- A diagnostic test with sensitivity 67% and specificity 91% is applied to 2030 people to look for a disorder with a population prevalence of 1.48%
|Patients with bowel cancer|
(as confirmed on endoscopy)
|Condition positive||Condition negative||Prevalence
|Accuracy (ACC) = |
(TP) = 20
(2030 x 1.48% x 67%)
(FP) = 180
(2030 x (100 - 1.48%) x (100 - 91%))
|Positive predictive value (PPV), Precision
= TP / (TP + FP)
= 20 / (20 + 180)
|False discovery rate (FDR)|
(FN) = 10
(2030 x 1.48% x (100 - 67%))
(TN) = 1820
(2030 x (100 -1.48%) x 91%)
|False omission rate (FOR)
= FN / (FN + TN)
= 10 / (10 + 1820)
|Negative predictive value (NPV)|
= TN / (FN + TN)
= 1820 / (10 + 1820)
|TPR, Recall, Sensitivity
= TP / (TP + FN)
= 20 / (20 + 10)
|False positive rate (FPR),Fall-out, probability of false alarm
|Positive likelihood ratio (LR+)
|Diagnostic odds ratio (DOR) = LR+/
|F1 score = 2 · Precision · Recall/|
|False negative rate (FNR), Miss rate
|Specificity, Selectivity, True negative rate (TNR)
= TN / (FP + TN)
= 1820 / (180 + 1820)
|Negative likelihood ratio (LR−) |
- False positive rate (α) = type I error = 1 − specificity = FP / (FP + TN) = 180 / (180 + 1820) = 9%
- False negative rate (β) = type II error = 1 − sensitivity = FN / (TP + FN) = 10 / (20 + 10) = 33%
- Power = sensitivity = 1 − β
- Likelihood ratio positive = sensitivity / (1 − specificity) = 0.67 / (1 − 0.91) = 7.4
- Likelihood ratio negative = (1 − sensitivity) / specificity = (1 − 0.67) / 0.91 = 0.37
- Prevalence threshold = = 0.19 => 19.1%
This hypothetical screening test (fecal occult blood test) correctly identified two-thirds (66.7%) of patients with colorectal cancer.[a] Unfortunately, factoring in prevalence rates reveals that this hypothetical test has a high false positive rate, and it does not reliably identify colorectal cancer in the overall population of asymptomatic people (PPV = 10%).
On the other hand, this hypothetical test demonstrates very accurate detection of cancer-free individuals (NPV = 99.5%). Therefore, when used for routine colorectal cancer screening with asymptomatic adults, a negative result supplies important data for the patient and doctor, such as ruling out cancer as the cause of gastrointestinal symptoms or reassuring patients worried about developing colorectal cancer.
Estimation of errors in quoted sensitivity or specificity
Sensitivity and specificity values alone may be highly misleading. The 'worst-case' sensitivity or specificity must be calculated in order to avoid reliance on experiments with few results. For example, a particular test may easily show 100% sensitivity if tested against the gold standard four times, but a single additional test against the gold standard that gave a poor result would imply a sensitivity of only 80%. A common way to do this is to state the binomial proportion confidence interval, often calculated using a Wilson score interval.
Terminology in information retrieval
In information retrieval, the positive predictive value is called precision, and sensitivity is called recall. Unlike the Specificity vs Sensitivity tradeoff, these measures are both independent of the number of true negatives, which is generally unknown and much larger than the actual numbers of relevant and retrieved documents. This assumption of very large numbers of true negatives versus positives is rare in other applications.
In the traditional language of statistical hypothesis testing, the sensitivity of a test is called the statistical power of the test, although the word power in that context has a more general usage that is not applicable in the present context. A sensitive test will have fewer Type II errors.
- Yerushalmy J (1947). "Statistical problems in assessing methods of medical diagnosis with special reference to x-ray techniques". Public Health Reports. 62 (2): 1432–39. doi:10.2307/4586294. JSTOR 4586294. PMID 20340527.
- Fawcett, Tom (2006). "An Introduction to ROC Analysis" (PDF). Pattern Recognition Letters. 27 (8): 861–874. doi:10.1016/j.patrec.2005.10.010.
- Powers, David M W (2011). "Evaluation: From Precision, Recall and F-Measure to ROC, Informedness, Markedness & Correlation". Journal of Machine Learning Technologies. 2 (1): 37–63.
- Ting, Kai Ming (2011). Sammut, Claude; Webb, Geoffrey I (eds.). Encyclopedia of machine learning. Springer. doi:10.1007/978-0-387-30164-8. ISBN 978-0-387-30164-8.
- Brooks, Harold; Brown, Barb; Ebert, Beth; Ferro, Chris; Jolliffe, Ian; Koh, Tieh-Yong; Roebber, Paul; Stephenson, David (2015-01-26). "WWRP/WGNE Joint Working Group on Forecast Verification Research". Collaboration for Australian Weather and Climate Research. World Meteorological Organisation. Retrieved 2019-07-17.
- Chicco D, Jurman G (January 2020). "The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation". BMC Genomics. 21 (1): 6-1–6-13. doi:10.1186/s12864-019-6413-7. PMC 6941312. PMID 31898477.
- Tharwat A (August 2018). "Classification assessment methods". Applied Computing and Informatics. doi:10.1016/j.aci.2018.08.003.
- Altman DG, Bland JM (June 1994). "Diagnostic tests. 1: Sensitivity and specificity". BMJ. 308 (6943): 1552. doi:10.1136/bmj.308.6943.1552. PMC 2540489. PMID 8019315.
- "SpPins and SnNouts". Centre for Evidence Based Medicine (CEBM). Retrieved 26 December 2013.
- Mangrulkar R. "Diagnostic Reasoning I and II". Retrieved 24 January 2012.
- Balayla, Jacques. "Prevalence Threshold and the Geometry of Screening Curves." arXiv preprint arXiv:2006.00398 (2020).
- "Evidence-Based Diagnosis". Michigan State University. Archived from the original on 2013-07-06. Retrieved 2013-08-23.
- "Sensitivity and Specificity". Emory University Medical School Evidence Based Medicine course.
- Baron JA (Apr–Jun 1994). "Too bad it isn't true". Medical Decision Making. 14 (2): 107. doi:10.1177/0272989X9401400202. PMID 8028462. S2CID 44505648.
- Boyko EJ (Apr–Jun 1994). "Ruling out or ruling in disease with the most sensitive or specific diagnostic test: short cut or wrong turn?". Medical Decision Making. 14 (2): 175–9. doi:10.1177/0272989X9401400210. PMID 8028470. S2CID 31400167.
- Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M (July 2004). "Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution". BMJ. 329 (7459): 209–13. doi:10.1136/bmj.329.7459.209. PMC 487735. PMID 15271832.
- Fawcett, Tom (2006). "An Introduction to ROC Analysis". Pattern Recognition Letters. 27 (8): 861–874. doi:10.1016/j.patrec.2005.10.010.
- Powers, David M W (2011). "Evaluation: From Precision, Recall and F-Measure to ROC, Informedness, Markedness & Correlation". Journal of Machine Learning Technologies. 2 (1): 37–63. hdl:2328/27165.
- Gale SD, Perkel DJ (January 2010). "A basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition". The Journal of Neuroscience. 30 (3): 1027–37. doi:10.1523/JNEUROSCI.3585-09.2010. PMC 2824341. PMID 20089911.
- Macmillan NA, Creelman CD (15 September 2004). Detection Theory: A User's Guide. Psychology Press. p. 7. ISBN 978-1-4106-1114-7.
- Lin, Jennifer S.; Piper, Margaret A.; Perdue, Leslie A.; Rutter, Carolyn M.; Webber, Elizabeth M.; O’Connor, Elizabeth; Smith, Ning; Whitlock, Evelyn P. (21 June 2016). "Screening for Colorectal Cancer". JAMA. 315 (23): 2576–2594. doi:10.1001/jama.2016.3332. ISSN 0098-7484.
- Bénard, Florence; Barkun, Alan N.; Martel, Myriam; Renteln, Daniel von (7 January 2018). "Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations". World Journal of Gastroenterology. 24 (1): 124–138. doi:10.3748/wjg.v24.i1.124. PMC 5757117. PMID 29358889.
- "Diagnostic test online calculator calculates sensitivity, specificity, likelihood ratios and predictive values from a 2x2 table – calculator of confidence intervals for predictive parameters". medcalc.org.
- Altman DG, Bland JM (June 1994). "Diagnostic tests. 1: Sensitivity and specificity". BMJ. 308 (6943): 1552. doi:10.1136/bmj.308.6943.1552. PMC 2540489. PMID 8019315.
- Loong TW (September 2003). "Understanding sensitivity and specificity with the right side of the brain". BMJ. 327 (7417): 716–9. doi:10.1136/bmj.327.7417.716. PMC 200804. PMID 14512479.